Top

Published in:

01-12-2018 | Original Article

Oncogenic roles of serine–threonine kinase receptor-associated protein (STRAP) in osteosarcoma

Authors: Dumnoensun Pruksakorn, Jeerawan Klangjorhor, Kriengsak Lirdprapamongkol, Pimpisa Teeyakasem, Patsadakorn Sungngam, Parunya Chaiyawat, Areerak Phanphaisarn, Jongkolnee Settakorn, Chantragan Srisomsap

Published in: Cancer Chemotherapy and Pharmacology | Issue 6/2018

Abstract

Purpose

To validate the presence of serine–threonine kinase receptor-associated Protein (STRAP) in osteosarcoma tissue and to investigate the oncological role of STRAP in osteosarcoma.

Methods

Expression of STRAP protein in osteosarcoma tissue compared to soft callus (hyperactive bone healing tissue) and in multiple cell lines was examined using western blot analysis. Effects of STRAP silencing on cell proliferation, invasion, migration and re-implantability in chick chorioallantoic membrane (CAM) were observed in osteosarcoma cell lines (MNNG-HOS, 143B, and U2OS).

Results

The result demonstrated that STRAP was highly up-regulated in osteosarcoma tissues compared with the normal physiological bone healing tissue (soft callus). Expression level of STRAP was markedly high in osteosarcoma cell lines with aggressive phenotype. Upon STRAP silencing, invasion and migration, but not proliferative activity, were selectively modulated in high-expression-STRAP cell lines. In addition, STRAP silencing reduced the success rate of tumor implantation and growth of MNNG-HOS cells in CAM model.

Conclusions

Serine–threonine kinase receptor-associated protein is up-regulated during osteosarcoma progression. The presence of STRAP enhances osteosarcoma cell invasion, migration and re-implantation ability, factors which play a critical role in metastasis. Serine–threonine kinase receptor-associated protein and its related pathway are worthy for further exploration as a novel target for anti-metastasis agents.

Available only for authorised users

Tang N, Song WX, Luo J, Haydon RC, He TC (2008) Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res 466(9):2114–2130. https://doi.org/10.1007/s11999-008-0335-z CrossRefPubMedPubMedCentral

Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, Zoubek A, Jürgens H, Winkler K (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20(3):776–790CrossRefPubMed

Allison DC, Carney SC, Ahlmann ER, Hendifar A, Chawla S, Fedenko A, Angeles C, Menendez LR (2012) A meta-analysis of osteosarcoma outcomes in the modern medical era. Sarcoma 2012:704872. https://doi.org/10.1155/2012/704872 CrossRefPubMedPubMedCentral

Broadhead ML, Clark JC, Myers DE, Dass CR, Choong PF (2011) The molecular pathogenesis of osteosarcoma: a review. Sarcoma 2011:959248. https://doi.org/10.1155/2011/959248 CrossRefPubMedPubMedCentral

Carano RA, Filvaroff EH (2003) Angiogenesis and bone repair. Drug Discov Today 8(21):980–989CrossRefPubMed

Datta PK, Moses HL (2000) STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling. Mol Cell Biol 20(9):3157–3167CrossRefPubMedPubMedCentral

Chen G, Deng C, Li YP (2012) TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 8(2):272–288. https://doi.org/10.7150/ijbs.2929 CrossRefPubMedPubMedCentral

Maeda S, Hayashi M, Komiya S, Imamura T, Miyazono K (2004) Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells. EMBO J 23(3):552–563. https://doi.org/10.1038/sj.emboj.7600067 CrossRefPubMedPubMedCentral

Vukmirovic M, Manojlovic Z, Stefanovic B (2013) Serine-threonine kinase receptor-associated protein (STRAP) regulates translation of type I collagen mRNAs. Mol Cell Biol 33(19):3893–3906. https://doi.org/10.1128/MCB.00195-13 CrossRefPubMedPubMedCentral

10.

Halder SK, Anumanthan G, Maddula R, Mann J, Chytil A, Gonzalez AL, Washington MK, Moses HL, Beauchamp RD, Datta PK (2006) Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Cancer Res 66(12):6156–6166. https://doi.org/10.1158/0008-5472.CAN-05-3261 CrossRefPubMed

11.

Franchi A, Arganini L, Baroni G, Calzolari A, Capanna R, Campanacci D, Caldora P, Masi L, Brandi ML, Zampi G (1998) Expression of transforming growth factor beta isoforms in osteosarcoma variants: association of TGF beta 1 with high-grade osteosarcomas. J Pathol 185 (3):284–289. https://doi.org/10.1002/(SICI)1096-9896(199807)185:3%3C284::AID-PATH94%3E3.0.CO;2-Z CrossRefPubMed

12.

Weil D, Garçon L, Harper M, Duménil D, Dautry F, Kress M (2002) Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells. Biotechniques 33(6):1244–1248CrossRefPubMed

13.

Pruksakorn D, Teeyakasem P, Klangjorhor J, Chaiyawat P, Settakorn J, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Pothacharoen P, Srisomsap C (2016) Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma. Int J Oncol 49(3):903–912. https://doi.org/10.3892/ijo.2016.3601 CrossRefPubMedPubMedCentral

14.

Balke M, Neumann A, Kersting C, Agelopoulos K, Gebert C, Gosheger G, Buerger H, Hagedorn M (2010) Morphologic characterization of osteosarcoma growth on the chick chorioallantoic membrane. BMC Res Notes 3:58. https://doi.org/10.1186/1756-0500-3-58 CrossRefPubMedPubMedCentral

15.

Ribatti D, Nico B, Morbidelli L, Donnini S, Ziche M, Vacca A, Roncali L, Presta M (2001) Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis. J Vasc Res 38(4):389–397. doi:51070CrossRefPubMed

16.

Chaiyawat P, Pruksakorn D, Phanphaisarn A, Teeyakasem P, Klangjorhor J, Settakorn J (2017) Expression patterns of class I histone deacetylases in osteosarcoma: a novel prognostic marker with potential therapeutic implications. Mod Pathol. https://doi.org/10.1038/modpathol.2017.125 CrossRefPubMedPubMedCentral

17.

Reiner JE, Datta PK (2011) TGF-beta-dependent and -independent roles of STRAP in cancer. Front Biosci (Landmark Ed) 16:105–115CrossRef

18.

Datta PK, Chytil A, Gorska AE, Moses HL (1998) Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling. J Biol Chem 273(52):34671–34674CrossRefPubMed

19.

Xu S, Yang S, Sun G, Huang W, Zhang Y (2014) Transforming growth factor-beta polymorphisms and serum level in the development of osteosarcoma. DNA Cell Biol 33(11):802–806. https://doi.org/10.1089/dna.2014.2527 CrossRefPubMed

20.

Lamora A, Talbot J, Bougras G, Amiaud J, Leduc M, Chesneau J, Taurelle J, Stresing V, Le Deley MC, Heymann MF, Heymann D, Redini F, Verrecchia F (2014) Overexpression of smad7 blocks primary tumor growth and lung metastasis development in osteosarcoma. Clin Cancer Res 20(19):5097–5112. https://doi.org/10.1158/1078-0432.CCR-13-3191 CrossRefPubMed

21.

Lamora A, Mullard M, Amiaud J, Brion R, Heymann D, Redini F, Verrecchia F (2015) Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases. Oncotarget 6(16):14413–14427. https://doi.org/10.18632/oncotarget.3891 CrossRefPubMedPubMedCentral

22.

Lauvrak SU, Munthe E, Kresse SH, Stratford EW, Namlos HM, Meza-Zepeda LA, Myklebost O (2013) Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. Br J Cancer 109(8):2228–2236. https://doi.org/10.1038/bjc.2013.549 CrossRefPubMedPubMedCentral

23.

Pautke C, Schieker M, Tischer T, Kolk A, Neth P, Mutschler W, Milz S (2004) Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts. Anticancer Res 24(6):3743–3748PubMed

24.

Tejeda-Munoz N, Robles-Flores M (2015) Glycogen synthase kinase 3 in Wnt signaling pathway and cancer. IUBMB Life 67(12):914–922. https://doi.org/10.1002/iub.1454 CrossRefPubMed

25.

Yuan G, Zhang B, Yang S, Jin L, Datta A, Bae S, Chen X, Datta PK (2016) Novel role of STRAP in progression and metastasis of colorectal cancer through Wnt/beta-catenin signaling. Oncotarget 7(13):16023–16037. https://doi.org/10.18632/oncotarget.7532 CrossRefPubMedPubMedCentral

26.

Yilmaz M, Christofori G (2010) Mechanisms of motility in metastasizing cells. Mol Cancer Res 8(5):629–642. https://doi.org/10.1158/1541-7786.MCR-10-0139 CrossRefPubMed

27.

Jin L, Datta PK (2014) Oncogenic STRAP functions as a novel negative regulator of E-cadherin and p21(Cip1) by modulating the transcription factor Sp1. Cell Cycle 13(24):3909–3920. https://doi.org/10.4161/15384101.2014.973310 CrossRefPubMedPubMedCentral

28.

Demir R, Dimmler A, Naschberger E, Demir I, Papadopoulos T, Melling N, Sturzl M, Hohenberger W (2009) Malignant progression of invasive tumour cells seen in hypoxia present an accumulation of beta-catenin in the nucleus at the tumour front. Exp Mol Pathol 87(2):109–116. https://doi.org/10.1016/j.yexmp.2009.05.004 CrossRefPubMed

29.

Krakhmal NV, Zavyalova MV, Denisov EV, Vtorushin SV, Perelmuter VM (2015) Cancer invasion: patterns and mechanisms. Acta Naturae 7(2):17–28PubMedPubMedCentral

30.

Lokman NA, Elder AS, Ricciardelli C, Oehler MK (2012) Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. Int J Mol Sci 13(8):9959–9970. https://doi.org/10.3390/ijms13089959 CrossRefPubMedPubMedCentral

31.

Ribatti D (2017) The chick embryo chorioallantoic membrane (CAM) assay. Reprod Toxicol 70:97–101. https://doi.org/10.1016/j.reprotox.2016.11.004 CrossRefPubMed

Title: Oncogenic roles of serine–threonine kinase receptor-associated protein (STRAP) in osteosarcoma
Authors: Dumnoensun Pruksakorn
Jeerawan Klangjorhor
Kriengsak Lirdprapamongkol
Pimpisa Teeyakasem
Patsadakorn Sungngam
Parunya Chaiyawat
Areerak Phanphaisarn
Jongkolnee Settakorn
Chantragan Srisomsap
Publication date: 01-12-2018
Publisher: Springer Berlin Heidelberg
Published in: Cancer Chemotherapy and Pharmacology / Issue 6/2018
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI: https://doi.org/10.1007/s00280-018-3696-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 6/2018

The maximum chemiluminescence intensity predicts severe neutropenia in gemcitabine-treated patients with pancreatic or biliary tract cancer

Enhancing 5-fluorouracil efficacy through suppression of PKM2 in colorectal cancer cells

Pharmacokinetic evaluation of the PNC disassembler metarrestin in wild-type and Pdx1-Cre;LSL-KrasG12D/+;Tp53R172H/+ (KPC) mice, a genetically engineered model of pancreatic cancer

Autophagy therapeutics: preclinical basis and initial clinical studies

Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer

Acknowledgement of reviewers 2017

Keynote webinar | Spotlight on antibody–drug conjugates in cancer